Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
wSp Vaccine for Preventing Pneumococcal Colonization in Young Children
NCT07216430Phase 2Recruiting
- Sponsor
- Serum Life Sciences
- Start
- Sep 2025
- Primary completion
- Jun 2028
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of wSp vaccine in acute otitis media (AOM), sponsored by Serum Life Sciences. Started Sep 2025; status: recruiting.
02
Drugs
wSp vaccine
03
Conditions
acute otitis media (AOM)
Beyond the preview
Go deeper on NCT07216430.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07216430.